ESICM News

THE ARISE TRIAL RESULTS


Sandra Peake discusses results from the highly-anticipated ARISE Study. This multi-centre, randomised controlled trial examined the effect of early goal-directed therapy, compared to standard care, on 90-day mortality in patients presenting to the Emergency Department with severe sepsis in Australasia. These results were presented at the Hot Topics Session at LIVES 2014 in Barcelona and simultaneously published in NEJM

Watch the presentation below:


<Back to the news list
Comment on this news Comment on this news
To respond to this article, thank you for identifying
ReactionsReactions (0)